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Nonwoven gauzesFrom ancientness, suitable materials have been developed to cover the wounds in order to prevent infec-
tions and promote proper wound healing. In this study, the successful development of functionalized
nonwoven gauzes with liposomes entrapping anti-inﬂammatory piroxicam is reported. Piroxicam is a
non-steroidal anti-inﬂammatory drug (NSAID) that can suppress a persistent inﬂammatory response,
leading to improved wound healing. The results demonstrated that the highest NSAID concentration
released is achieved when gauzes were previously cationized with poly(diallyldimethylammonium chlo-
ride) (PDDA) and high concentration of phospholipid (3000 lM) and multilamellar liposomes (MLVs)
were used. MLVs were also the best vehicle considering their biocompatibility with skin human ﬁbro-
blasts, where no toxicity was observed for neither of the tested conditions.
The developed functionalized gauzes can be, therefore, a good strategy to treat chronic wounds.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Wound healing is a complex process that includes inﬂamma-
tion, which is basically a defensive phenomenon yet often leading
to serious pathological conditions if unbalanced. In fact, the inﬂam-
matory response is needed for the recruitment and activation of
dermal cells to the wound site, which leads to the secretion of
extracellular matrix, cell proliferation, angiogenesis, granulation
tissue formation and eventual reepithelization of the wound [1].
Additionally, it has been well documented that an inﬂammatory
response is needed to prevent infection, which if not eradicated
impairs the healing process [1–3]. On the other hand, the state of
chronic inﬂammation, that characterize chronic wounds, creates
a proteolytic environment that is mediated by inﬁltration of
inﬂammatory cells at the wound site, as well as prolonged
overexpression of pro-inﬂammatory cytokines and chemokines
that inhibit the normal progression of wound healing [2]. There-
fore, non-steroidal anti-inﬂammatory drugs (NSAIDs), which are
the principal pharmacological treatment for inﬂammatory dis-
eases, could suppress the imbalances of chronic inﬂammation,
leading to wound healing and restoration of the skin barrierfunction. This feature is very important, once that skin serves as
a protective barrier against the environment and loss of cutaneous
integrity, in the absence of adequate repair, can lead to major
disability or even death [4].
Topical administration of NSAIDs can control severe side effects,
as observed in gastrointestinal tract and kidney [5,6]. Besides this
advantage over conventional oral and intravenous dosage forms,
topical drug delivery offers many other beneﬁts, such as ﬁrst pass
metabolism avoidance, pain minimization and patient compliance
[7]. Consequently, there is a growing interest in the optimization
of NSAID-carrier formulations to improve cutaneous delivery of
these drugs. An example is liposomal formulations that have gained
a considerable interest over the last decades. Additionally, advanced
medical textiles is an area in expansion in theﬁeld ofwoundhealing.
Textile materials favour wound occlusion, exit of bacteria, exudates
transport and drug dispensation with much reduced distress to the
patient [8–10]. In addition, prolonged contact time of a drug with a
bodily tissue, through the use of gauzes, for example, can signiﬁ-
cantly improve the clinical performance of many drugs. These
improvements range from better treatment of local pathologies to
improved drug bioavailability and controlled release, to enhanced
patient compliance [11]. Thus, textiles’ functionalizationwith drugs
that counteract the progression of chronic wound inﬂammation is a
promising approach to develop new textile-basedwound dressings.
H. Ferreira et al. / Reactive & Functional Polymers 73 (2013) 1328–1334 1329In this context, the aim of this study was to entrap a NSAID, spe-
ciﬁcally piroxicam, into liposomes and then proceed to the attach-
ment of those delivery systems to the nonwoven gauzes. Two types
of liposomes were used, namely multilamellar liposomes (MLVs)
and large unilamellar liposomes (LUVs), to investigate the best
liposomal vehicle for the NSAID under study. MLVs present great
variations in the vesicle size, size distribution and lamellarity,
while LUVs are formed by a single bilayer of lipids, with well de-
ﬁned size [12,13]. Besides the liposomes, the inﬂuence of EPC con-
centration (1500 and 3000 lM) in liposomes properties and
NSAID release it was also investigated. The production was
followed by liposomes characterization which included the
determination of size, polydispersity index (PDI), zeta-potential,
morphology, drug entrapment efﬁciency and cytotoxicity.
Liposomes were then attached to nonwoven gauzes to produce a
functionalized biomaterial, with great potential for biomedical
application. It was also explored if activation of the surface gauzes
with a cationic product could lead to an enhancement of liposome
attachment onto nonwoven gauzes. Finally, besides to evaluate the
presence of liposomes in the gauzes surface, it was proceeded to
the quantiﬁcation of piroxicam released.2. Experimental
2.1. Materials and equipment
The chemical reagents were purchased from Sigma–Aldrich and
all were used as supplied. The nonwoven gauzes (composed by 67%
of viscose and 33% of polyester, 3,1915 ± 0,0077 g/m2) were com-
mercial available in a local pharmacy. The BJ5ta cell line (telome-
rase-immortalized human normal skin ﬁbroblasts) was
purchased from the European Collection of Cell Cultures (ECACC)
and cultured according to American type culture collection (ATCC)
recommendations.
The absorbance measurements were recorded at 25.0 ± 0.1 C
with a Hekios c ThermoSpectronic spectrophotometer (Unicam).
A Spectraﬂash spectrophotometer (illuminant D65 at 600 nm for
Comassie Brilliant Blue G250 and 540 nm for Reactive Red 66),
from Datacolor International, was used to measure the K/S values.
The Malvern zetasizer NS (Malvern Instruments) equipment
was used to determine the size distribution and the zeta-potential
of the particles, using photon correlation spectroscopy (PCS) and
electrophoretic laser doppler anemometry, respectively, at
25.0 ± 0.1 C.
The shape and morphology of liposomes, as well as their attach-
ment into gauzes were observed using a scanning electronic micro-
scope model NOVA Nano SEM 200 FEI.
The ultrasound equipment was composed of a probe type
(20 kHz Sonics and Materials Vibracell CV 33) ﬁtted with a 3 mm
diameter titaniummicro-tip. Power delivery was controlled as per-
centage amplitude (40%) and 19 mm was the depth, measured
from the base of the vessel, used. The reaction vessel was an open
glass cell (diameter 19 mm and height 75 mm), containing 16 mL
of sample solution. The sonochemical reactor temperature was
controlled via a thermo-stated water bath with a freezer exchanger
placed within a thermo jacket cell.
The laboratory scale machine used to dye was an AHIBA Spec-
tradye, from Datacolor International (Loorenstrasse 9, CH-8305
Dietlikon, Switzerland), with infrared temperature control.2.2. Liposomes preparation and drug incorporation
Liposomes were prepared by the thin ﬁlm hydration method
[14]. A known amount of EPC was dissolved in chloroform and
was mixed with a chloroform solution of piroxicam to obtainliposomes entrapping this drug. The organic solvent was then
evaporated in a rotary evaporator and the lipid ﬁlm formed was
left at least 3 h to remove residual traces of the chloroform. The
resulting dried lipid ﬁlm was dispersed by addition of phosphate
buffered saline solution (PBS; 0.01 M, pH 7.4) and the resultant
mixture was then vortexes above the phase transition temperature
(room temperature) to yield MLVs. The sonication of MLVs suspen-
sion was carried out with a total treatment of 21 min monitored in
3 min increments, at 25 ± 1 C. A pulsed duty cycle of 8 s on, 2 s off
was used for all the experiments with indicated power delivery of
40%. After LUVs preparation, the suspension was submitted to a
centrifugation (2500g, 15 min) to remove larger lipid aggregates
and titanium particles released from the sonicator probe [15].
Liposomes were separated from non-entrapped drug by size
exclusion chromatography using a Sephadex G-25 M column con-
taining 0.15% kathan Gc as preservative (GE-Healthcare) and equil-
ibrated with PBS buffer before use.
2.3. Determination of size, PDI and zeta-potential
Size distribution and zeta-potential values of EPC liposomes,
with and without incorporated drug, were determined at pH 7.4
(PBS), at 25.0 ± 0.1 C. Lipid concentration was kept constant at
approximately 500 lM.
2.4. Quantiﬁcation of NSAID entrapment efﬁciency in liposomes
The entrapment efﬁciency of piroxicam into vesicular systems
was evaluated by UV spectrophotometry, at 353 nm. Entrapment
efﬁciency refers to the ratio of quantity entrapped/adsorbed drug
in relation to the total (theoretical) amount of drug used for lipo-
somes production. Therefore, the entrapment efﬁciency of piroxi-
cam was determined by:
Entrapment efficiency ð%Þ ¼ ½Piroxicami  ½Piroxicamf½Piroxixamf
 100 ð1Þ
where [Piroxicam]i and [Piroxicam]f is the initial and ﬁnal NSAID
concentration, respectively, in supernatant after separation of the
vesicular systems.
Measurements were recorded in triplicate and the results were
expressed as mean value ± standard deviation (SD).
2.5. Determination of liposomes morphology
The characterization of the overall structure and shape of lipo-
somes was performed using STEM. For this analysis, the liposomes
suspension was dropped in Copper grids with carbon ﬁlm 400
meshes, 3 mm diameter.
2.6. Chemical activation of gauzes
The chemical activation of nonwoven gauzes comprised the
cationization, as well as the determination of cationization efﬁ-
ciency on the gauzes surface.
The gauzes were cationized using the exhaust method already
described [16]. The cationization was performed in sealed, stain-
less steel pots of 120 cm3 in capacity using a laboratory scale dye-
ing machine, previously referred in Section 2.1. The treatment was
carried out using a material:liquor ratio of 1:20, 10% (of weight of
the fabric) of poly(diallyldimethylammonium chloride) (PDDA)
and 5 g L1 of sodium hydroxide, over 60 min at 50 C. Afterwards,
the gauzes were collected and washed thoroughly with deionised
water.
Table 1
Size (nm), PDI and zeta-potential (mV) values obtained for MLVs and LUVs of EPC
(1500 and 3000 lM) incorporating piroxicam.
Liposome Size PDI Zeta-potential
Type [EPC] (lM)
MLVs 1500 1660 ± 9.20 0.99 ± 0.01 1.31 ± 0.05
3000 1800 ± 11.3 1.00 ± 0.00 2.06 ± 0.08
LUVs 1500 66.76 ± 2.01 0.28 ± 0.03 1.34 ± 0.03
3000 71.41 ± 1.20 0.31 ± 0.09 1.90 ± 0.02
1330 H. Ferreira et al. / Reactive & Functional Polymers 73 (2013) 1328–1334The cationization at the surface of nonwoven gauzes was ana-
lysed by staining of treated samples and controls (nonwoven
gauzes without cationization treatment) with Comassie Brilliant
Blue G250 or Reactive Red 66. The staining was executed in an AHI-
BA machine (referred in Section 2.1), using 1 g L1 of dyes, at 60 C
for 60 min. After staining, the samples were washed with deionised
water until no more dye could be detected in the washing solution.
The colour measurements were determined using the spectro-
photometer, previously referred in Section 2.1. The ratio between
absorption coefﬁcient (K) and scattering coefﬁcient (S) is related
to light reﬂection (R) by applying Kubelka–Munk’s law, at each
wavelength, and it is proportional to dye concentration [17,18]:
K
S
¼ 1 R
2
2 R ð2Þ
The colour strength was evaluated as K/S at maximum absorp-
tion wavelength.
2.7. Attachment of liposomes entrapping piroxicam onto gauzes
The attachment of liposomes was achieved by incubating the
different types of liposomes with the gauzes in a water shaking
bath, at room temperature (25 C), over 24 h under constant shack-
ing (50 rpm). After incubation, the samples were removed and
washed with deionized water.
The presence of liposomes on gauzes samples was evaluated by
SEM (the samples were coated with gold, in vacuum), and by using
two dyes, namely Comassie Brilliant Blue G250 and Reactive Red
66, present in two different concentrations, 0.25 and 1 g L1. The
colour measurements in the nonwoven gauzes were determined
using the same conditions referred in Section 2.6. These tests were
performed simultaneously with controls (nonwoven gauzes,
cationized and non-cationized, without liposomes).
2.8. Quantiﬁcation of NSAID release from liposomes attached onto
gauzes
The release of piroxicam by the vesicular systems attached onto
nonwoven gauzes (0.07 g) was assessed by incubation of the tex-
tile samples in deionised water (pH 5.5), to mimic the skin pH (5.5–
5.6) [19]. The volume of deionised water used was 3.5 mL and in
the ﬁrst 6 h was changed after every hour. After that, the medium
was changed in each 24 h. At determined time points, aliquots
were taken, and the piroxicam release was monitored by absor-
bance measurements at wavelength of 356 nm. The release studies
were performed in triplicate and for a period of 72 h.
2.9. Cytotoxicity evaluation
The cytotoxicity of LUVs and MLVs containing piroxicam was
evaluated using normal human skin ﬁbroblasts (BJ5ta). The BJ5ta
cell line was maintained according to ATCC recommendations (4
parts Dulbecco’s modiﬁed Eagle’s medium (DMEM) containing
4 mM L-glutamine, 4.5 g L1 glucose, 1.5 g L1 sodium bicarbonate
and 1 part of Medium 199, supplemented with 10% (v/v) of fetal
bovine serum (FBS), 1% (v/v) of Penicillin/Streptomycin solution
and 10 lg mL1 Hygromycin B). The cells were maintained at
37 C in a humidiﬁed atmosphere of 5% CO2. Culture medium
was refreshed every 2 to 3 days. Cells were seeded at a density of
10  103 cells/100 lL/well on 96-well tissue culture polystyrene
(TCPS) plates (TPP, Switzerland), in the day before the experiments,
and then exposed to different concentrations of liposomes entrap-
ping or not piroxicam, as well as, of NSAID under study. At 24, 48
and 72 h of exposure, cell viability was determined using the ala-
marBlue assay (Invitrogen, EUA).Data are expressed as means with standard errors of the means.
Two-way ANOVA followed by post hoc Bonferroni test (GraphPad
Prism 5.0 for Windows) was employed with statistically signiﬁcant
differences when P < 0.05.3. Results and discussion
3.1. Size distribution and zeta-potential of liposomes
Table 1 shows the results of size and PDI obtained for liposomes
incorporating piroxicam. As expected, the MLVs population pre-
sents a higher medium size and PDI, due to their heterogeneity.
The zeta-potential of the liposomes after separation of non-en-
trapped NSAID was also evaluated to obtain an indication of their
surface potential. In Table 1, it is also possible to verify that there
was no signiﬁcant difference on the zeta-potential values between
LUVs and MLVs with piroxicam (the variations were smaller than
3 mV) and liposomes without drug (1.01 mV). These results
are in agreement with the presence of zwitterionic forms of this
oxicam, at pH 7.4 [20]. Consequently, piroxicam has less inﬂuence
over membrane surface potential.
3.2. Liposomes morphology
STEM microphotographs, present in Fig. 1, evidences that lipo-
somes (MLVs and LUVs), with or without piroxicam, present a sim-
ilarly spherical shape. The spherical shape observed, apart from
other parameter, would offer the highest potential for controlled
release and protection of incorporated drugs, as they provide min-
imum contact with the aqueous environment, as well as the lon-
gest diffusion pathways. Comparing particles with any other
shape, spherical particles also require the smallest amount of sur-
face-active agent for stabilization, because of their small speciﬁc
surface area [21].
The results obtained with this technique were also in agree-
ment with PCS results, once that the particle size distribution
was very similar.
3.3. Piroxicam entrapment efﬁciency
The results obtained for the entrapment efﬁciency of piroxicam
by LUVs and MLVs of EPC, present in different concentrations, are
shown in Table 2. It is possible to conclude that the increase of
phospholipid concentration promoted a small increment of NSAID
entrapment, as expected, since piroxicam:EPC ratio was main-
tained. However, the results obtained for MLVs and LUVs, pro-
duced using the same EPC concentration, were signiﬁcantly
different. In fact, piroxicam may be located mainly between phos-
pholipids in the lipid bilayer [20], due to its hydrophobicity, which
also allows its solubilisation in chloroform and, consequently, its
inclusion in the lipid ﬁlm. Because LUVs present a higher curva-
ture, this may hinder adequate packaging of piroxicam molecules.
This data is also corroborated with literature, that refers multila-
mellar structures as being usually preferred to entrap hydrophobic
Fig. 1. STEM images of MLVs (50000 magniﬁcation) and LUVs (100000 magniﬁcation) without (a and b) or entrapping piroxicam (c and d).
Table 2
Entrapment efﬁciency (%) of piroxicam into LUVs and MLVs of EPC present in different
concentrations (1500 and 3000 lM).
Liposome Entrapment efﬁciency (%)
Type [EPC] (lM)
MLVs 1500 34.7 ± 3.2
3000 36.6 ± 4.0
LUVs 1500 12.5 ± 3.6
3000 17.2 ± 2.7
Table 3
K/S (±SD) values for the cationized and non-cationized nonwoven gauzes, with LUVs
or MLVs (0,  1500 and  3000 lM of EPC) entrapping piroxicam, dyed with
Comassie brilliant blue G250 (1 g L1).
Liposome K/S
Type [EPC] (lM) Nonwoven non-cationized Nonwoven cationized
– 0 0.83 ± 0.05 12.24 ± 0.25
LUVs 1500 0.64 ± 0.02 9.99 ± 0.32
3000 0.61 ± 0.04 9.87 ± 0.33
MLVs 1500 0.72 ± 0.03 10.76 ± 0.27
3000 0.67 ± 0.02 10.20 ± 0.30
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appropriate for the encapsulation of hydrophilic molecules [12,13].
3.4. Attachment of liposomes entrapping piroxicam onto gauzes
The potential of activating the nonwoven gauzes surface to at-
tach the developed devices was explored. As the vesicules present
negative surface charge, the activation of the gauzes surface, in or-
der to obtain a positive charge, could be a good strategy to increase
their attachment. It would promote a higher electrostatic interac-
tion between the negative surface charge of the vesicular systems
and the positive surface charge of the gauzes.
The attachment of the liposomes containing piroxicam, onto
cationized and non cationized nonwoven gauzes, was evaluated
using the dyes Comassie Brilliant Blue G250 and Reactive Red 66,
as previously referred in Section 2.7. After staining, it was not pos-
sible to observe with naked eye a signiﬁcant difference in colour
between samples and controls, as obtained in a preliminary study
performed with cotton fabric (data not shown). Consequently, itwas necessary to measure the K/S values in order to verify if the
presence of liposomes led to a decrease of the colour strength,
compared to controls, as veriﬁed in the preliminary study. Indeed,
liposomes can form a lipid barrier at the gauze’s surface, which im-
pairs the binding of the dye to the ﬁbre and, consequently, a de-
crease in K/S values.
In Table 3, the K/S values represent an example of the data ob-
tained for the evaluation of liposomes entrapping piroxicam
attachment using the dye Comassie. From this Table, it is possible
to conclude that, as expected, the presence of liposomes onto
gauzes contributes towards a reduction in K/S values. Additionally,
these results demonstrate a superior decrease of K/S values for
cationized samples, suggesting a higher attachment of the lipo-
somes onto positively charged surfaces of the ﬁbres. A higher de-
crease of K/S values was also observed when the highest
concentration of EPC was used, suggesting a superior liposome
attachment in these experimental conditions.
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Fig. 3. In vitro release proﬁle of piroxicam entrapped in MLVs (a) and LUVs (b) of
EPC (1500 and 3000 lM), from cationized and non-cationized nonwoven gauzes.
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and non-cationized gauzes (without liposomes), it is also possible
to conclude that the cationization occurred efﬁciently, as the val-
ues are higher for the cationized samples. In fact, both dyes have
more afﬁnity for the cationized ﬁbre, given the electrostatic inter-
actions between their negative and the positive charge present on
the cationized gauzes’ surfaces.
The results obtained from the staining assays were corrobo-
rated by SEM analysis. Indeed, the morphological analysis of the ﬁ-
bres testiﬁes the attachment of the liposomes containing
piroxicam onto the nonwoven gauzes (Fig. 2).
3.5. In vitro release proﬁle of piroxicam from liposomes attached onto
gauzes
As shown in Fig. 3, the release of the anti-inﬂammatory drug oc-
curs mainly in the initial hours. It is also possible to verify that
when the highest concentration of phospholipid (3000 lM) was
used, the NSAID concentration in the aqueous phase increased. In
fact, as previously referred, the greater is the number of MLVs or
LUVs in suspension, the higher is the liposomes’ attachment onto
the substrate. Moreover, comparing the NSAID release proﬁle from
MLVs and LUVs, a higher concentration of piroxicam in the aque-
ous phase was obtained for the gauzes loaded with MLVs. This
can be related with the size of this type of liposomes, once that
being bigger favours retention onto the gauze’s structure. Indeed,
the porous nature of the textile inﬂuences the attachment of the
particles once that, as previously referred in Section 3.4, with cot-
ton fabric the differences in colour after samples dyeing were vis-
ible for the different liposome types. Nonwoven gauzes structure is
less closed and compact than cotton fabrics, which can hold vesic-
ular systems to a smaller extent, especially if they are smaller.
Comparing piroxicam concentrations released by the liposomes
attached onto cationized and non-cationized gauzes (Fig. 3), it is
possible to conclude that the activation of gauzes led to higher con-
centrations of the NSAID in the aqueous environment. Indeed, the
enhancement of electrostatic interactions between liposomes and
cationized gauzes promotes a higher yield of attachment and, con-
sequently, of subsequent NSAID release.
3.6. Cytotoxicity evaluation
The biocompatibility of the two types of liposomes, without or
with entrapped piroxicam, was assessed in normal human skin
ﬁbroblasts (BJ5ta cell line) upon 24, 48 and 72 h of contact. Before
evaluating the biocompatibility of the different NSAID-liposome
formulations, the cytotoxicity associated with the drug piroxicam
was assessed in the same cell line. The results obtained showed
that concentrations below 500 lM of piroxicam did not signiﬁ-
cantly affect the viability of human skin ﬁbroblasts, up to a
maximum period of 72 h (cell viability above80%).Fig. 2. SEM microphotographs (10000 magniﬁcation) of cationized nonwoven gauzThe data, in Fig. 4, indicates that MLVs with or without en-
trapped piroxicam, at the tested concentrations and contact times,
did not induce toxicity for the chosen mammalian cell model
(P > 0.05). A similar result was obtained for the different concentra-
tions of LUVs tested (Fig. 4). However, when this type of liposomes
was enriched with piroxicam, statistically signiﬁcant differences in
relative toxicity were obtained for concentrations above 250 lM of
EPC when compared to the life control, for all exposure durations
(P < 0.05 for 500 lM of EPC and P < 0.001 for 750 lM of EPC). Com-
parisons of different concentrations of LUVs containing piroxicam
with the other tested samples were also performed. Statistically
signiﬁcant differences were obtained for the 500 lM and 750 lMes without liposomes (a) and with MLVs (b) or LUVs (c) entrapping piroxicam.
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Fig. 4. BJ5ta cell viability at 24, 48 and 72 h of culture with different concentrations of MLVs (a) and LUVs (b) without or entrapping piroxicam (100, 250, 500 and 750 lM).
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The toxicity achieved for these two samples can be related with
the process of LUVs production. It is well known that ultrasonic
irradiation of water produces free radicals [22], which contributes
to lipid oxidation and to the modiﬁcation of piroxicam chemical
structure, given its antioxidant activity [23]. Nevertheless, the rela-
tionship between the NSAID concentration (14 lM) in the
250 lM of LUVs and the synovial ﬂuid and plasma concentrations
of piroxicam found in some studies after topical and oral adminis-
tration [24], indicate that these liposomes can be suitable for the
treatment of inﬂammatory conditions.4. Conclusions
This work exploited the functionalization of nonwoven gauzes,
with liposomes entrapping piroxicam, as a promising approach to
develop new textile-based wound dressings.
The chemical activation of gauzes showed to be a good strategy
to attach liposomes at the ﬁbres surface, leading to higher NSAID
concentration release into the aqueous environment. The same
trend was observed by increasing EPC concentration, as well as
by using MLVs, as drug carriers. In fact, MLVs showed to be the bet-
ter vehicle even in terms of citotoxicity, as their cytocompatibility
was veriﬁed for all conditions. In this sense, the functionalized
gauzes developed are a promising tool to control topical chronic
inﬂammatory conditions and boost wound healing processes.Acknowledgements
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